Clinical Trial Results TV
October 14, 2005: Managing Heart Failure in 2005: The New American Heart Association/American College of Cardiology Guidelines
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* 2005 Heart Failure Guideline
* Evidence-based drug selection
* Cardiac Resynchronization Treatment
* ICDs and Stage C Heart Failure


Dr. Joe Rogers has indicated that he is a member of the GlaxoSmithKline Speakers Bureau.

The guest faculty, William Abraham, MD, has indicated that he receives research/grant
support from Amgen, Biotronik, CHF Solutions, GlaxoSmithKline, The Heart Failure Society
of America, National Institues of Health, Medtronic Inc., Myogen Inc., Orqis Medical,
Otsuka Maryland Research Institute, Paracor In., and Scios Inc. He acts as a
consultant/speakers bureau member for Amgen, Astra Zeneca, Boehringer Ingelheim, CHF
Solutions, GlaxoSmithKline, Guidant Corp., Medtronic Inc., Merck & Co. Inc., Pfizer,
ResMed, Respironics, Scios Inc., and St. Jude Medical. He is a member of the advisory
boards for CardioKine, Cardiokinetix Inc., CHF Solutions, The Department of Veterans
Affairs Cooperative Studies Program, National Institutes of Health, and Savacor Inc. He
receives/has received honoraria from Astra Zeneca, Boehringer Ingelheim, GlaxoSmithKline,
Guidant Corp., Medtronic Inc., Merck & Co. Inc., Pfizer, ResMed, Repsironics, Scios
Inc., and St. Jude Medical.



Managing Heart Failure in 2005: The New American Heart Association/American College of Cardiology Guidelines

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
09-25-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted